These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 35154137
21. Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine. Zeng M, Xu Q, Pichichero ME. Vaccine; 2007 May 04; 25(18):3588-94. PubMed ID: 17293013 [Abstract] [Full Text] [Related]
22. Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies. Ramirez K, Ditamo Y, Galen JE, Baillie LW, Pasetti MF. Vaccine; 2010 Aug 23; 28(37):6065-75. PubMed ID: 20619377 [Abstract] [Full Text] [Related]
26. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis. Stokes MG, Titball RW, Neeson BN, Galen JE, Walker NJ, Stagg AJ, Jenner DC, Thwaite JE, Nataro JP, Baillie LW, Atkins HS. Infect Immun; 2007 Apr 23; 75(4):1827-34. PubMed ID: 17145938 [Abstract] [Full Text] [Related]
27. Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthrax. Oscherwitz J, Yu F, Jacobs JL, Cease KB. Clin Vaccine Immunol; 2013 Mar 23; 20(3):341-9. PubMed ID: 23283638 [Abstract] [Full Text] [Related]
28. Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvant. Feinen B, Petrovsky N, Verma A, Merkel TJ. Clin Vaccine Immunol; 2014 Apr 23; 21(4):580-6. PubMed ID: 24554695 [Abstract] [Full Text] [Related]
29. Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax. Skoble J, Beaber JW, Gao Y, Lovchik JA, Sower LE, Liu W, Luckett W, Peterson JW, Calendar R, Portnoy DA, Lyons CR, Dubensky TW. Infect Immun; 2009 Apr 23; 77(4):1649-63. PubMed ID: 19168734 [Abstract] [Full Text] [Related]
33. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Welkos S, Little S, Friedlander A, Fritz D, Fellows P. Microbiology (Reading); 2001 Jun 23; 147(Pt 6):1677-1685. PubMed ID: 11390699 [Abstract] [Full Text] [Related]
36. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores. Hermanson G, Whitlow V, Parker S, Tonsky K, Rusalov D, Ferrari M, Lalor P, Komai M, Mere R, Bell M, Brenneman K, Mateczun A, Evans T, Kaslow D, Galloway D, Hobart P. Proc Natl Acad Sci U S A; 2004 Sep 14; 101(37):13601-6. PubMed ID: 15342913 [Abstract] [Full Text] [Related]
39. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes. Chitlaru T, Israeli M, Rotem S, Elia U, Bar-Haim E, Ehrlich S, Cohen O, Shafferman A. Vaccine; 2017 Oct 20; 35(44):6030-6040. PubMed ID: 28342664 [Abstract] [Full Text] [Related]
40. A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen. Gwinn WM, Johnson BT, Kirwan SM, Sobel AE, Abraham SN, Gunn MD, Staats HF. Vaccine; 2013 Mar 01; 31(11):1480-9. PubMed ID: 23352329 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]